Boehringer Ingelheim GmbH
Member: Silver
Since: 06.12.2013
Since: 06.12.2013
Leoforos Andrea Syngrou 340, 176 73 Kallithea, Greece
-
26.10.2021BOEHRINGER INGELHEIM: Increases commitments to sustainable development
Boehringer Ingelheim invests in health innovation and collaborations to expand access and improve healthcare for 50 million people in vulnerable communities by 2030 -
02.04.2021BOEHRINGER INGELHEIM: Sees positive business momentum in 2020 despite impact of COVID-19
The company spent 3.7 billion EUR on R&D, 7% more than in the previous year. This represents the highest annual investment in R&D -
23.03.2021Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Obesity is a complex cardiometabolic disease with growing global prevalence and limited treatment options that are not sufficiently effective or are associated with adverse events -
23.02.2021Award: Boehringer Ingelheim is Global Top Employer 2021
Boehringer Ingelheim performs particularly well in strategy, corporate culture and employee involvement -
12.01.2021Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
Boehringer Ingelheim has set up a dedicated Quantum Lab with leading experts - MORE